MHRA policy paper on the 'Impact of AI on the regulation of medical products'
Lloyd Price
MAY 13, 2024
By working with international organizations like the IMDRF, the US FDA and Health Canada, they aim to ensure the safe and responsible use of AI in medicine, keeping the UK at the leading edge of global best practices. This aligns with their five core principles, suggesting they will prioritise safety while embracing new technologies.
Let's personalize your content